The LIM-only Protein DRAL/FHL2 Interacts with and Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein*

Members of the four-and-a-half-LIM domain (FHL) protein family, which are expressed in a tissue- and stage-specific manner, have been reported previously to function as transcriptional coactivators. One of these is the p53-inducible protein DRAL/FHL2 (where DRAL is down-regulated in rhabdomyosarcoma LIM domain protein). In this work, we identified potential binding partners for DRAL/FHL2 using an inducible yeast two-hybrid system. We present evidence of a functional interaction between the promyelocytic leukemia zinc finger protein (PLZF) and DRAL/FHL2. PLZF is a sequence-specific transcriptional repressor whose function relies on recruitment of corepressors that form part of the histone deacetylase complex involved in chromatin remodeling. DRAL/FHL2 interacts specifically with PLZFin vitro and in vivo and augments transcriptional repression mediated by PLZF. This is the first reported incidence of a bona fide FHL protein-mediated corepression and supports the notion of these proteins having a role as coregulators of tissue-specific gene expression.

[1]  S. Mohan,et al.  Insulin-like Growth Factor-binding Protein 5 (IGFBP-5) Interacts with a Four and a Half LIM Protein 2 (FHL2)* , 2002, The Journal of Biological Chemistry.

[2]  J. Licht,et al.  Critical Residues within the BTB Domain of PLZF and Bcl-6 Modulate Interaction with Corepressors , 2002, Molecular and Cellular Biology.

[3]  A. Bosserhoff,et al.  The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus , 2002, The EMBO journal.

[4]  P. Pandolfi,et al.  The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor. , 2001, Blood.

[5]  C. Osborne,et al.  Forkhead Homologue in Rhabdomyosarcoma Functions as a Bifunctional Nuclear Receptor-interacting Protein with Both Coactivator and Corepressor Functions* , 2001, The Journal of Biological Chemistry.

[6]  R. Bassel-Duby,et al.  Cardiac-Specific LIM Protein FHL2 Modifies the Hypertrophic Response to &bgr;-Adrenergic Stimulation , 2001, Circulation.

[7]  P. Pandolfi,et al.  Role of PML and PML-RARα in Mad-Mediated Transcriptional Repression , 2001 .

[8]  M. Waye,et al.  Protein–protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two‐fusion fluorescence resonance energy transfer (FRET) , 2001, Journal of cellular biochemistry.

[9]  M. Schmid,et al.  Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF , 2000, Oncogene.

[10]  P. Sassone-Corsi,et al.  A Family of LIM-Only Transcriptional Coactivators: Tissue-Specific Expression and Selective Activation of CREB and CREM , 2000, Molecular and Cellular Biology.

[11]  B. Schäfer,et al.  Dral Is a P53-Responsive Gene Whose Four and a Half Lim Domain Protein Product Induces Apoptosis , 2000, The Journal of cell biology.

[12]  A. Sonnenberg,et al.  The LIM-only Protein DRAL/FHL2 Binds to the Cytoplasmic Domain of Several α and β Integrin Chains and Is Recruited to Adhesion Complexes* , 2000, The Journal of Biological Chemistry.

[13]  J. Ross,et al.  FHL2 (SLIM3) Is Not Essential for Cardiac Development and Function , 2000, Molecular and Cellular Biology.

[14]  T. Tabira,et al.  Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein. , 2000, Human molecular genetics.

[15]  Qiang Zhou,et al.  Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system , 2000, Mechanisms of Development.

[16]  P. Pandolfi,et al.  Plzf regulates limb and axial skeletal patterning , 2000, Nature Genetics.

[17]  J. Licht,et al.  The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein , 2000, Molecular and Cellular Biology.

[18]  S. Tsui,et al.  Protein‐protein interaction of FHL2, a LIM domain protein preferentially expressed in human heart, with hCDC47 , 2000, Journal of cellular biochemistry.

[19]  I. Bach.  The LIM domain: regulation by association , 2000, Mechanisms of Development.

[20]  N. Klugbauer,et al.  Cysteine-rich Protein 2, a Novel Substrate for cGMP Kinase I in Enteric Neurons and Intestinal Smooth Muscle* , 2000, The Journal of Biological Chemistry.

[21]  R. Schüle,et al.  FHL2, a novel tissue‐specific coactivator of the androgen receptor , 2000, The EMBO journal.

[22]  T. Rabbitts,et al.  The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Licht,et al.  The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase. , 1999, Nucleic acids research.

[24]  Susan S. Brown,et al.  Characterization of Two Isoforms of the Skeletal Muscle LIM Protein 1, SLIM1 , 1999, The Journal of Biological Chemistry.

[25]  U. Walter,et al.  An α-Actinin Binding Site of Zyxin Is Essential for Subcellular Zyxin Localization and α-Actinin Recruitment* , 1999, The Journal of Biological Chemistry.

[26]  E. Ehler,et al.  Different domains of the M-band protein myomesin are involved in myosin binding and M-band targeting. , 1999, Molecular biology of the cell.

[27]  R. Evans,et al.  Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Paolo Sassone-Corsi,et al.  CBP-independent activation of CREM and CREB by the LIM-only protein ACT , 1999, Nature.

[29]  Y. Tu,et al.  The LIM-Only Protein PINCH Directly Interacts with Integrin-Linked Kinase and Is Recruited to Integrin-Rich Sites in Spreading Cells , 1999, Molecular and Cellular Biology.

[30]  E. Dmitrovsky,et al.  Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A , 1999, Oncogene.

[31]  M. Privalsky,et al.  Components of the SMRT Corepressor Complex Exhibit Distinctive Interactions with the POZ Domain Oncoproteins PLZF, PLZF-RARα, and BCL-6* , 1998, The Journal of Biological Chemistry.

[32]  J. Licht,et al.  The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis , 1998, Molecular and Cellular Biology.

[33]  Chi-Wai Wong,et al.  Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein , 1998, Oncogene.

[34]  K P Fung,et al.  Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. , 1998, Gene.

[35]  J. J. Breen,et al.  LIM domains: multiple roles as adapters and functional modifiers in protein interactions. , 1998, Trends in genetics : TIG.

[36]  E. Cuppen,et al.  PDZ motifs in PTP-BL and RIL bind to internal protein segments in the LIM domain protein RIL. , 1998, Molecular biology of the cell.

[37]  S. Minucci,et al.  Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.

[38]  S. Inoue,et al.  Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.

[39]  T. Honjo,et al.  LIM Protein KyoT2 Negatively Regulates Transcription by Association with the RBP-J DNA-Binding Protein , 1998, Molecular and Cellular Biology.

[40]  H. A. Louis,et al.  Comparison of Three Members of the Cysteine-rich Protein Family Reveals Functional Conservation and Divergent Patterns of Gene Expression* , 1997, The Journal of Biological Chemistry.

[41]  J. Licht,et al.  Sequence-specific DNA Binding and Transcriptional Regulation by the Promyelocytic Leukemia Zinc Finger Protein* , 1997, The Journal of Biological Chemistry.

[42]  A. Dejean,et al.  SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia , 1997 .

[43]  S. F. Konieczny,et al.  Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD , 1997, Molecular and cellular biology.

[44]  T. Rabbitts,et al.  The LIM‐only protein Lmo2 is a bridging molecule assembling an erythroid, DNA‐binding complex which includes the TAL1, E47, GATA‐1 and Ldb1/NLI proteins , 1997, The EMBO journal.

[45]  L. Chin,et al.  Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression , 1997, nature.

[46]  B. Schäfer,et al.  Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. , 1997, DNA and cell biology.

[47]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[48]  T. Rabbitts,et al.  Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. , 1996, The EMBO journal.

[49]  J. Licht,et al.  Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. , 1996, Oncogene.

[50]  R. Krumlauf,et al.  Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. , 1995, Blood.

[51]  D. Song,et al.  The LIM/double zinc-finger motif functions as a protein dimerization domain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Beckerle,et al.  The LIM domain is a modular protein-binding interface , 1994, Cell.

[53]  P. Caroni,et al.  Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation , 1994, Cell.

[54]  A. Zelent,et al.  PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[55]  张哉根,et al.  Leu-M , 1991 .

[56]  M. Waye,et al.  Interaction of the heart‐specific LIM domain protein, FHL2, with DNA‐binding nuclear protein, hNP220 , 2002, Journal of cellular biochemistry.

[57]  S. Tsui,et al.  Translocation of a human focal adhesion LIM-only protein, FHL2, during myofibrillogenesis and identification of LIM2 as the principal determinants of FHL2 focal adhesion localization. , 2001, Cell motility and the cytoskeleton.